Ilkka Oyj
8.4.2026 18:00:00 CEST | Globenewswire | Press release
Ilkka Oyj: Acquisition of own shares on 8 April 2026
Ilkka Oyj: Acquisition of own shares on 8 April 2026
Ilkka Oyj Stock Exchange Release 8 April 2026, at 07:00 p.m. EEST
Ilkka Oyj: Acquisition of own shares on 8 April 2026
| Date | 8 April 2026 | |
| Exchange transaction | Buy | |
| Share trading code | ILKKA2 | |
| Amount, shares | 2,400 | |
| Average price/share (EUR) | 4.2767 | |
| Total cost (EUR) | 10,264.08 |
After the acquisitions Ilkka Oyj holds a total of 151,200 treasury shares (ILKKA2).
On behalf of Ilkka Oyj
Danske Bank A/S, Finland Branch
Antti Väliaho Jonathan Nyberg
For more information, please contact:
Olli Pirhonen, CEO, Ilkka Oyj
olli.pirhonen@ilkka.com
DISTRIBUTION
Nasdaq Helsinki
Main media
www.ilkka.com
Ilkka Oyj in brief
Ilkka is a marketing and technology company that offers professional, data and technology services in digital marketing and communications. The core of Ilkka's business is formed by the software company Liana, a pioneer in marketing and communication technology, and its Swedish subsidiary Ungapped; the leading expert in data-driven sales and marketing, Profinder; Finland's leading WordPress digital agency Evermade; Finland's leading social media marketing expert agency MySome; and the strategic B2B marketing partner Myynninmaailma. Our success relies heavily on knowing the entire purchase path and utilizing modern technology, data, and AI. Our international focus is particularly on Sweden and the emerging markets in the Middle East. The group's services are provided by approximately 330 marketing, technology, and data experts.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
Zymeworks Inc.24.10.2026 08:30:00 CEST | Press release
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom